Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | Corporate Executive VP & CCO | November 07, 2024 | November 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date November 07, 2024 · Filed November 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 23,337 |
Reported balance
After 2024-11-07 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2024-11-07 · Gift · Disposed 470 · Balance 23,337 F1: Reflects the exempt transfer pursuant to Rule 16a-13 of 965 shares held by the reporting person to William D. Barbo Revocable Trust. |
| Common StockSEC Table I · non-derivative | Direct | 2,468 |
Reported balance
Holding disclosure · report date 2024-11-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,468 |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the exempt transfer pursuant to Rule 16a-13 of 965 shares held by the reporting person to William D. Barbo Revocable Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $140.63 | $28,126.00 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 6 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,166 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 101 | $140.62 | $14,202.62 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 5 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,366 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $140.62 | $56,246.00 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 4 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,467 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $140.60 | $28,120.00 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 3 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,867 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 11 | $140.60 | $1,546.55 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 2 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,067 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,000 | $140.58 | $140,580.00 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 1 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,078 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 3,204 | $0.00 Strike: $109.34 | $0.00 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · derivative · entry 35 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,614 Underlying: Common Stock · 3,204 shares Expires 2023-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 6,984 | $0.00 Strike: $88.05 | $0.00 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · derivative · entry 34 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,985 Underlying: Common Stock · 6,984 shares Expires 2022-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 6,030 | $0.00 Strike: $73.70 | $0.00 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · derivative · entry 33 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,015 Underlying: Common Stock · 6,030 shares Expires 2021-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 2,158 | $0.00 Strike: $76.67 | $0.00 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · derivative · entry 32 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,158 Underlying: Common Stock · 2,158 shares Expires 2020-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 1,825 | $0.00 Strike: $59.41 | $0.00 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · derivative · entry 31 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,825 shares Expires 2021-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 69 | $140.58 | $9,699.68 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 30 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,078 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 706 | $140.57 | $99,242.42 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 29 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,147 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 408 | $140.56 | $57,348.48 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 28 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,853 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $140.56 | $56,222.00 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 27 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,261 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 2 | $140.55 | $281.09 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 26 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,661 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 800 | $140.54 | $112,432.00 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 25 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,663 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 17 | $140.54 | $2,389.10 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 24 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,463 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 133 | $140.53 | $18,690.49 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 23 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,480 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 8 | $140.53 | $1,124.20 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 22 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,613 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 422 | $140.52 | $59,299.44 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 21 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,621 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 61 | $140.52 | $8,571.42 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 20 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,043 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 35 | $140.51 | $4,917.68 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 19 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,104 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $140.49 | $14,048.50 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 18 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,139 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $140.48 | $14,048.00 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 17 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,239 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $140.48 | $14,047.50 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 16 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,339 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $140.47 | $28,094.00 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 15 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,439 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 30 | $140.47 | $4,213.95 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 14 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,639 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 33 | $140.46 | $4,635.18 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 13 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,669 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $140.43 | $42,129.00 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 12 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,702 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $140.42 | $28,084.00 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 11 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,002 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $140.41 | $28,082.00 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 10 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,202 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $140.40 | $14,040.00 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 9 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,402 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $140.35 | $56,140.00 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 8 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,502 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $140.33 | $14,033.00 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 7 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,902 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $140.27 | $56,108.00 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 6 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,002 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 3,204 | $109.34 | $350,325.36 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 5 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 6,984 | $88.05 | $614,941.20 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 4 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 6,030 | $73.70 | $444,411.00 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 3 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 2,158 | $76.67 | $165,453.86 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 2 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 1,825 | $59.41 | $108,423.25 |
DisclosureSEC source: 0001127602-19-009090 · form4.xml · nonDerivative · entry 1 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 14:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 273 | $145.31 | $39,669.63 |
DisclosureSEC source: 0001127602-19-008792 · form4.xml · nonDerivative · entry 1 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,419 Read SEC document |
| February 24, 2019 Filed Feb 26, 2019 19:41 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 322 | $144.67 | $46,583.74 |
DisclosureSEC source: 0001127602-19-008314 · form4.xml · nonDerivative · entry 3 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,692 Read SEC document |
| February 23, 2019 Filed Feb 26, 2019 19:41 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 316 | $144.67 | $45,715.72 |
DisclosureSEC source: 0001127602-19-008314 · form4.xml · nonDerivative · entry 2 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,014 Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 19:41 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 11,021 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001127602-19-008314 · form4.xml · derivative · entry 4 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,021 Underlying: Common Stock · 11,021 shares Expires 2024-02-22 F2 · derivative.exercise_date: Stock options vest as follows: 2,755 options vest one (1) year from the date of grant, 2,755 options vest two (2) years from the date of grant, 2,755 options vest three (3) years from the date of grant, and 2,756 options vest four (4) years from the date of grant. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 19:41 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-008314 · form4.xml · nonDerivative · entry 1 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,330 F1 · security: Consists of 2,585 unvested restricted stock units that vest as follows: 646 shares vest one (1) year from the date of issuance, 646 shares vest two (2) years from the date of issuance, 646 shares vest three (3) years from the date of issuance, and 647 shares vest four (4) years from the date of issuance. Read SEC document |
| January 30, 2019 Filed Feb 1, 2019 17:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 2,444 | $119.39 | $291,789.16 |
DisclosureSEC source: 0001127602-19-003322 · form4.xml · nonDerivative · entry 2 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,745 Read SEC document |
| January 30, 2019 Filed Feb 1, 2019 17:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 8,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-003322 · form4.xml · nonDerivative · entry 1 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,189 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 26, 2016. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 00:49 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 202 | $107.82 | $21,779.64 |
DisclosureSEC source: 0001127602-18-009447 · form4.xml · nonDerivative · entry 1 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,980 Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 21:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 218 | $108.95 | $23,751.10 |
DisclosureSEC source: 0001127602-18-009080 · form4.xml · nonDerivative · entry 1 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,182 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.